Franklin U.S. Core Equity (IU) Fund ABT Holdings History
Franklin U.S. Core Equity (IU) Fund's Abbott Laboratories Holding Summary
As of 2025-04-30, FRANKLIN FUND ALLOCATOR SERIES held 74,295.00 shares of Abbott Laboratories(ABT), totaling $9.71 Mil. This investment constitutes 1.02% of their stock portfolio, and FRANKLIN FUND ALLOCATOR SERIES now holds 0% of the outstanding Abbott Laboratories(ABT) stock.
The initial trade took place in 2021Q2. And since then Franklin U.S. Core Equity (IU) Fund has made 3 purchases of ABT, at an average price of $117.00, for a total of 163,890.00 shares. In addition, there have been 4 sales at an average price of $113.90 for 89,595.00 shares. Based on historical transaction data and ABT's current price of $132.02, Franklin U.S. Core Equity (IU) Fund's estimated gain on his ABT holdings is $838,639.64, reflecting a 4.37% gain to date.
Franklin U.S. Core Equity (IU) Fund ABT ($132.02) Holding Chart
Franklin U.S. Core Equity (IU) Fund ABT ($132.02) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1